CONCERTA is contraindicated: in patients known to be hypersensitive to methylphenidate or other components of the product; in patients with glaucoma; during treatment with monoamine oxidase (MAO) inhibitors, and also within a minimum of 14 days following discontinuation of a MAO inhibitor (hypertensive crises may result) (see Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
